BioWorld Science

Aug. 17, 2006

View Archived Issues

Novel treatment strategies for cancer covered in recent patent literature

Read More

Recent patents describe new analgesic agents

Read More

Recent patents describe novel agents for anxiety, depression, psychosis etc.

Read More

Recent Universitaetsklinikum Muenster patent discloses novel diagnostic agents

Read More

Amoxicillin PULSYS demonstrates bacterial eradication in adults and adolescents

Read More

Visual acuity stabilization eight weeks after a single dose of Sirna-027

Read More

RabiCide to enter preclinical testing for rabies by 2007

Read More

Acrux and Population Council amend transdermal contraceptive agreement

Read More

Novartis, Schering-Plough to develop once-daily therapy for asthma and COPD

Read More

Additional information for Herceptin sBLA deemed major amendment

Read More

Gilead completes acquisition of Corus Pharma

Read More

Genzyme seeks to expand European label of Synvisc

Read More

Pharmexa discontinues phase II study of HER-2 Protein AutoVac

Read More

Approvable letter for eprodisate for AA amyloidosis

Read More

Delta opioid agonist provides effective analgesia in preclinical bone cancer pain

Read More

Jak2 validated as a therapeutic target for CML

Read More

Phase IIa asthma study of LAB CGRP completes enrollment

Read More

Nastech studies PYY3-36 nasal spray in dose-ranging obesity study

Read More

Depomed completes phase I study with GERD compound

Read More

DG-051 enters phase I for prevention of heart attack

Read More

Phase II trial studies Iomai's vaccine patch for travelers' diarrhea

Read More

Targeting 5-HT2A receptor-mediated nociception relieves painful symptoms following tissue injury

Read More

PI3Kdelta inhibition with IC-87114 has shown benefit in a murine model of allergic asthma

Read More

Galvus filed for European approval in type 2 diabetes

Read More

Soltamox launched in the U.S.

Read More